Certara Investor Day Presentation Deck
December 2021, 91 slides
  1. Certara
  2. Related Decks
  3. Investor Day Presentation Decks
accelerating medicines investor day | Certara
| Certara
agenda | Certara
remarks remarks chief executive officer chief executive officer a | Certara
at a glance | Certara
accelerating medicines using and technology | Certara
advancing drug programs with our suite of solutions | Certara
predictive power of | Certara
streamlining trials and optimizing outcomes | Certara
differentiated strengths fuel global expansion | Certara
large growing end markets | Certara
drug grows in complexity and cost | Certara
powerful flywheel effect fuels momentum and adoption | Certara
driving innovation new products and updates in pinnacle | Certara
powerful flywheel effect fuels momentum and adoption | Certara
increasing regulatory adoption | Certara
powerful flywheel effect fuels momentum and adoption | Certara
growing number of publications by industry and clinical pharmacology clinical pharmacology | Certara
powerful flywheel effect fuels momentum and adoption | Certara
drug approvals using | Certara
disciplined strategic approach to a | Certara
diverse global team of leading experts | Certara
diverse global team of leading experts | Certara
proven growth strategy | Certara
our speakers today | Certara
innovating to transform traditional president of | Certara
| Certara
industry leading with more than users | Certara
platform overview president of | Certara
platform spans discovery to post approval support | Certara
mechanistic is used to quantitatively predict without human or animal studies | Certara
mechanistic is used to quantitatively predict without human or animal studies | Certara
mechanistic is used to quantitatively predict without human or animal studies simulator | Certara
platform leading mechanistic | Certara
growing regulatory adoption and support | Certara
industry and academic adoption | Certara
simulating virtual patients and waiving clinical studies | Certara
novel drug approval using simulator | Certara
areas of significant impact with simulator | Certara
regulatory priority to increase access to generics | Certara
emerging technologies in | Certara
platform approach to quantitative systems pharmacology i | Certara
addressing safety issues consistently and | Certara
simulator vice president of | Certara
simulator framework with virtual patients | Certara
numerous applications across | Certara
case study using simulator | Certara
model predicted untested scenarios | Certara
model used to inform dose adjustments in label moderate reduce to me | Certara
track record of scientific and regulatory milestones | Certara
clinical development opportunity | Certara
pain points in clinical phase significant opportunity | Certara
pain points in clinical phase significant opportunity | Certara
reducing errors ensuring quality and increasing speed pinnacle | Certara
validating all clinical data submitted to and | Certara
mining insights to inform critical decisions | Certara
regulatory adopted for required analyses | Certara
assuring and accelerating regulatory success | Certara
next study is informed by a | Certara
use case from top company a a | Certara
technology driven services maximizing client value creation edge president of regulatory access smith president of integrated drug development | Certara
technology driven services | Certara
sustained drivers of our growth | Certara
integrated suite of services powered by technology | Certara
accelerating patient safety narratives with technology | Certara
codex for model based meta analysis | Certara
insights from the covid codex | Certara
tale of two covid therapies | Certara
different customer journeys depending on their needs | Certara
practice areas with differentiated tools and support | Certara
advancing a novel rare pediatric drug to approval | Certara
virtual drug development for a neglected tropical disease | Certara
meeting customers where they are | Certara
people passion and purpose | Certara
educating to influence a | Certara
| Certara
financial update and outlook chief financial officer | Certara
track record of strong performance | Certara
bookings growth drives strong visibility | Certara
acquisition of pinnacle a leader in data standardization | Certara
final guidance no longer requires purchase accounting adjustment | Certara
outlook nas | Certara
concluding remarks chief executive officer | Certara
full to advance a drug program | Certara
investment highlights | Certara
accelerating medicines investor day | Certara
appendix | Certara
reconciliation of net income loss to adjusted | Certara
reconciliation of net income loss to adjusted net income loss | Certara
reconciliation of diluted earnings per share to adjusted diluted earnings per share | Certara
notes to reconciliations | Certara
See More
Certara
Investor Day Presentation Decks
Health Information Services Decks
Healthcare Decks
Explore Topics
Drug development
Recent decks by Certara
Investor Presentation
May 2022
See all presentations by Certara (2 decks)
Related decks
ATAI
Investor Presentation
October 2022
ATAI
Investor Day
January 2022
ATAI
Investor Presentation
June 2020
AbCellera
Investor Conference
May 2022
ATAI
Investor Presentation
November 2022
AbCellera
Investor Conference
September 2021
AbCellera
Results
August 2021
AbCellera
Investor Conference
April 2023
Recent decks by Certara
See all presentations (2 decks)
Investor Presentation
May 2022
ATAI
Investor Presentation
October 2022
ATAI
Investor Day
January 2022
ATAI
Investor Presentation
June 2020
AbCellera
Investor Conference
May 2022
ATAI
Investor Presentation
November 2022
AbCellera
Investor Conference
September 2021
AbCellera
Results
August 2021
AbCellera
Investor Conference
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io